Reacted MultiMin
Natural health product licensed in Canada
- Licence holder
- Ortho Molecular Products Inc.
- NPN or DIN-HM
- 80082287
- Status
- Active licence
- Licence date
- 9 January 2018
- Revision date
- 18 January 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 190 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 190 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 25 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 90 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bore Source : Acide borique | 11.25 mcg | Not calculated |
| Sulfate d'oxyde de vanadium Source : Sulfate de vanadyle | 0.75 mg | Not calculated |
| Manganèse Source : Diglycinate de manganèse (II) | 1.25 mg | 5,000 µg |
| Acide aminoacétique Source : Glycine | 38.13 mcg | Not calculated |
| Chrome Source : Nicotinate de chrome (III) | 47.5 mcg | 190 µg |
| Molybdène Source : Diglycinate de molybdène (VI) | 11.25 mcg | 45 µg |
| Sélénium Source : Glycinate de sélénium | 47.5 mcg | 190 µg |
| Magnésium Source : Glycinate de lysyl de magnésium | 37.5 mg | 150,000 µg |
| Magnésium Source : Malate de dimagnésium | 37.5 mg | 150,000 µg |
| Zinc Source : Diglycinate de zinc | 6.25 mg | 25,000 µg |
| Magnésium Source : Bisglycinate de magnésium | 37.5 mg | 150,000 µg |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Chlorhydrate de bétaine | 11.25 mg | Not calculated |
| Calcium Source : Diglycinate de calcium | 75 mg | 300,000 µg |
| Potassium Source : Glycinate de potassium | 22.5 mg | 90,000 µg |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Acide stéarique, Cellulose microcristalline, Acide citrique, Hypromellose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of minerals, factors in the maintenance of good health. Source of minerals, factors in normal growth and development. Source of minerals to support biological functions which play a key role in the maintenance of good health. Multi-mineral supplement. Helps in the development and maintenance of bones. Helps to maintain the body's ability to metabolize nutrients. Provides support for healthy glucose metabolism. Helps to maintain normal blood glucose levels. Helps in connective tissue formation. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps protect against oxidative stress. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to maintain normal function of the thyroid gland. Helps in energy metabolism and tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin. Helps in the development and maintenance of bones and teeth (especially in young adulthood). Adequate calcium (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Source of electrolytes for the maintenance of good health. Helps in the process of normal regulation of cell division and specialisation. Helps to maintain normal muscle function. Helps to prevent selenium, manganese, zinc and chromium deficiencies. Helps to prevent molybdenum deficiencies in men and non-pregnant non-breastfeeding women. Source of an amino acid involved in muscle protein synthesis. Workout supplement. Athletic support.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80082287
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging